Frontpage » Tag » company

Tobacco industry appears to have evaded FDA ban on 'light' cigarette descriptors

New research from Harvard School of Public Health (HPSH) shows that one year after the federal government passed a law banning word descriptors such as "light," "mild," and "low" on cigarette packages, smokers can still easily ...

Health created Mar 13, 2013 | popularity 5 / 5 (1) | comments 0

Industry self-regulation permits junk food ads in programming popular with children

(Medical Xpress)—Loopholes in industry self-regulation allow food companies to continue to reach large numbers of children with advertising for unhealthy products—such as fast food, candy, and cookies—during ...

Health created Mar 12, 2013 | popularity not rated yet | comments 1

New drug shows promise in ability to fight rare type of breast cancer

Researchers in the University of Delaware's Department of Biological Sciences are investigating a new drug that has shown positive results in early tests of its ability to fight a rare and aggressive form ...

Cancer created Mar 08, 2013 | popularity 5 / 5 (3) | comments 0

Report supports tackling tobacco consumption, improving vaccination access to reduce global cancer burden

Combating the tobacco industry's tactics in the world's poorest countries as well as ensuring the best cancer vaccines are available to those most in need are key in order to reduce the number of cancer deaths worldwide, ...

Cancer created Mar 07, 2013 | popularity not rated yet | comments 0 | with audio podcast

Merck Q4 net profit more than doubles

Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.

Other created Mar 07, 2013 | popularity 2 / 5 (1) | comments 0

New research shows anti-wrinkle cream chemical works

(Medical Xpress)—University of Reading researchers have found that a chemical used in some anti-wrinkle creams can nearly double the amount of the protein collagen needed to give skin its elasticity.

Medications created Mar 06, 2013 | popularity 4 / 5 (1) | comments 1

Engineering and autism: Chemical engineer investigates autism spectrum disorders

(Medical Xpress)—The University of Delaware's Prasad Dhurjati is a chemical engineer whose background includes systems engineering, biotechnology and artificial intelligence. Yet recently, he has been investigating autism ...

Autism spectrum disorders created Mar 05, 2013 | popularity 2 / 5 (2) | comments 2

Pharmaceutical companies: An $84 million marketing effort in the District of Columbia

Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according ...

Medications created Mar 01, 2013 | popularity not rated yet | comments 0

Deworming important for children's health, has limited impact on infection in wider communities

Although they have an important impact on children's health and education, school-based deworming programmes have a limited impact on the level of infection in the wider community, according to a mathematical modeling study ...

Diseases, Conditions, Syndromes created Feb 28, 2013 | popularity not rated yet | comments 0

Lawsuit charges weigh on Bayer profits again

(AP)—Charges for lawsuits over its birth control pills weighed on Bayer AG's earnings once again during the fourth quarter of 2012.

Other created Feb 28, 2013 | popularity not rated yet | comments 0

FDA: Omontys injection pulled from market

(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis ...

Medications created Feb 26, 2013 | popularity not rated yet | comments 0

Royalty Pharma offers to buy Elan for about $6.5B (Update)

Royalty Pharma said Monday that it wants to buy Elan Corp. PLC for about $6.5 billion, but has yet to receive a formal response from the Irish drugmaker.

Other created Feb 25, 2013 | popularity not rated yet | comments 0

Natalizumab shows promise for teens with multiple sclerosis

(HealthDay)—Natalizumab may be safe in pediatric multiple sclerosis (MS) patients with highly active disease, according to a small study published online Feb. 18 in JAMA Neurology.

Neuroscience created Feb 22, 2013 | popularity 5 / 5 (3) | comments 0

Antidepressants alone are not enough

We should reconsider how we use antidepressants more effectively. The latest studies have shown that antidepressants restore the capacity of certain areas of the brain to repair abnormal neural pathways. According to neuroscientist ...

Psychology & Psychiatry created Feb 22, 2013 | popularity 5 / 5 (4) | comments 2

Setting the record straight on Medicare's overhead costs

The traditional Medicare program allocates only 1 percent of total spending to overhead compared with 6 percent when the privatized portion of Medicare, known as Medicare Advantage, is included, according to a study in the ...

Health created Feb 20, 2013 | popularity not rated yet | comments 0